Literature DB >> 25469652

Low dispositional mindfulness predicts self-medication of negative emotion with prescription opioids.

Eric L Garland1, Adam W Hanley, Elizabeth A Thomas, Paul Knoll, Jeffrey Ferraro.   

Abstract

OBJECTIVES: Although evidence is mounting that opioids are abused to self-medicate negative emotions, little is known about the traits and factors linked to opioid self-medication. One potentially crucial psychological correlate is dispositional mindfulness. Thus, the purpose of this study was to describe the prevalence of opioid self-medication among a treatment-seeking sample of prescription opioid-dependent individuals and specifically examine the relationship between dispositional mindfulness and opioid self-medication.
METHODS: Participants in acute detoxification or intensive outpatient treatment for prescription opioid dependence (n = 79) were recruited from a regional hospital's addictions treatment unit for this cross-sectional study. Sociodemographic data were collected along with surveys of opioid self-medication, pain level, and dispositional mindfulness.
RESULTS: Self-medication of negative affective states with opioids was quite common, with 94.9% of individuals sampled reporting self-medication behaviors. In adjusted analyses, individuals engaging in more frequent opioid use tended to self-medicate negative emotions with opioids more often than those engaging in more intermittent opioid use (β = 0.33; P < 0.05). Importantly, irrespective of opioid use frequency and other clinical and sociodemographic covariates, dispositional mindfulness was inversely associated with opioid self-medication (β = -0.42; P < 0.001), such that less mindful individuals reported using opioids more frequently to self-medicate negative emotions.
CONCLUSIONS: Self-medication of negative emotions with opioids was prevalent in this sample and related to low dispositional mindfulness. Plausibly, increasing mindfulness may decrease opioid self-medication. Addictive automaticity and emotion regulation are discussed as potential mechanisms linking low dispositional mindfulness and self-medication.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25469652      PMCID: PMC4310788          DOI: 10.1097/ADM.0000000000000090

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  38 in total

1.  Comparative reliability and validity of chronic pain intensity measures.

Authors:  M P Jensen; J A Turner; J M Romano; L D Fisher
Journal:  Pain       Date:  1999-11       Impact factor: 6.961

2.  The benefits of being present: mindfulness and its role in psychological well-being.

Authors:  Kirk Warren Brown; Richard M Ryan
Journal:  J Pers Soc Psychol       Date:  2003-04

3.  Potential influences on initiation and persistence of extramedical prescription pain reliever use in the US population.

Authors:  Krista Dowling; Carla L Storr; Howard D Chilcoat
Journal:  Clin J Pain       Date:  2006 Nov-Dec       Impact factor: 3.442

Review 4.  Addiction and the brain antireward system.

Authors:  George F Koob; Michel Le Moal
Journal:  Annu Rev Psychol       Date:  2008       Impact factor: 24.137

5.  Chronic stress causes frontostriatal reorganization and affects decision-making.

Authors:  Eduardo Dias-Ferreira; João C Sousa; Irene Melo; Pedro Morgado; Ana R Mesquita; João J Cerqueira; Rui M Costa; Nuno Sousa
Journal:  Science       Date:  2009-07-31       Impact factor: 47.728

6.  Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Kevin P Conway; Wilson Compton; Frederick S Stinson; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

7.  Thought suppression, impaired regulation of urges, and Addiction-Stroop predict affect-modulated cue-reactivity among alcohol dependent adults.

Authors:  Eric L Garland; Kristin Carter; Katie Ropes; Matthew O Howard
Journal:  Biol Psychol       Date:  2011-10-01       Impact factor: 3.251

8.  Dispositional Mindfulness Co-varies with Self-Reported Positive Reappraisal.

Authors:  Adam W Hanley; Eric L Garland
Journal:  Pers Individ Dif       Date:  2014-08-01

9.  Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions.

Authors:  S S Martins; M C Fenton; K M Keyes; C Blanco; H Zhu; C L Storr
Journal:  Psychol Med       Date:  2011-10-17       Impact factor: 7.723

10.  Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.

Authors:  Sarah Bowen; Neharika Chawla; Susan E Collins; Katie Witkiewitz; Sharon Hsu; Joel Grow; Seema Clifasefi; Michelle Garner; Anne Douglass; Mary E Larimer; Alan Marlatt
Journal:  Subst Abus       Date:  2009 Oct-Dec       Impact factor: 3.716

View more
  17 in total

1.  Medical use, non-medical use and use disorders of benzodiazepines and prescription opioids in adults: Differences by insurance status.

Authors:  Vítor Soares Tardelli; Thiago Marques Fidalgo; Julian Santaella; Silvia S Martins
Journal:  Drug Alcohol Depend       Date:  2019-09-21       Impact factor: 4.492

2.  Psychosocial factors and multiple health risk behaviors among early adolescents: a latent profile analysis.

Authors:  Christopher M Warren; Afton Kechter; Georgia Christodoulou; Christopher Cappelli; Mary Ann Pentz
Journal:  J Behav Med       Date:  2020-04-22

3.  Behavioral preference for viewing drug v. pleasant images predicts current and future opioid misuse among chronic pain patients.

Authors:  Scott J Moeller; Adam W Hanley; Eric L Garland
Journal:  Psychol Med       Date:  2019-04-15       Impact factor: 7.723

4.  Deficits in autonomic indices of emotion regulation and reward processing associated with prescription opioid use and misuse.

Authors:  Eric L Garland; Craig J Bryan; Yoshio Nakamura; Brett Froeliger; Matthew O Howard
Journal:  Psychopharmacology (Berl)       Date:  2016-12-08       Impact factor: 4.530

Review 5.  Emotion regulation as a transdiagnostic factor underlying co-occurring chronic pain and problematic opioid use.

Authors:  Rachel V Aaron; Patrick H Finan; Stephen T Wegener; Francis J Keefe; Mark A Lumley
Journal:  Am Psychol       Date:  2020-09

6.  Examining Relationships between Gender, Opioid Dependence, and Distress Tolerance among Patients in Substance Use Disorder Treatment.

Authors:  Matthew T Tull; Keith A Edmonds; Courtney N Forbes; Julia R Richmond; Jason P Rose; Michael D Anestis; Kim L Gratz
Journal:  Subst Use Misuse       Date:  2020-03-20       Impact factor: 2.164

7.  Affective dysregulation predicts incident nonmedical prescription analgesic use among college students.

Authors:  Christine K Morioka; Donna E Howard; Kimberly M Caldeira; Min Qi Wang; Amelia M Arria
Journal:  Addict Behav       Date:  2017-09-01       Impact factor: 3.913

8.  Neural mechanisms supporting the relationship between dispositional mindfulness and pain.

Authors:  Fadel Zeidan; Tim Salomons; Suzan R Farris; Nichole M Emerson; Adrienne Adler-Neal; Youngkyoo Jung; Robert C Coghill
Journal:  Pain       Date:  2018-12       Impact factor: 6.961

9.  Pain, psychological flexibility, and continued substance use in a predominantly hispanic adult sample receiving methadone treatment for opioid use disorder.

Authors:  Kristen D Rosen; Megan E Curtis; Jennifer S Potter
Journal:  Drug Alcohol Depend       Date:  2019-10-28       Impact factor: 4.492

10.  Thought suppression as a mediator of the association between depressed mood and prescription opioid craving among chronic pain patients.

Authors:  Eric L Garland; Samantha M Brown; Matthew O Howard
Journal:  J Behav Med       Date:  2015-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.